157 related articles for article (PubMed ID: 20236515)
1. MFSD2A is a novel lung tumor suppressor gene modulating cell cycle and matrix attachment.
Spinola M; Falvella FS; Colombo F; Sullivan JP; Shames DS; Girard L; Spessotto P; Minna JD; Dragani TA
Mol Cancer; 2010 Mar; 9():62. PubMed ID: 20236515
[TBL] [Abstract][Full Text] [Related]
2. C10ORF97 is a novel tumor-suppressor gene of non-small-cell lung cancer and a functional variant of this gene increases the risk of non-small-cell lung cancer.
Shi Y; Chen J; Li Z; Zhang Z; Yu H; Sun K; Wang X; Song X; Wang Y; Zhen Y; Yang T; Lou K; Zhang Y; Zhang G; Hu Y; Ji J; Hui R
Oncogene; 2011 Sep; 30(39):4107-17. PubMed ID: 21499297
[TBL] [Abstract][Full Text] [Related]
3. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of LATS2 in non-small cell lung cancer promoted the growth and motility of cancer cells.
Yao F; Liu H; Li Z; Zhong C; Fang W
Tumour Biol; 2015 Mar; 36(3):2049-57. PubMed ID: 25391426
[TBL] [Abstract][Full Text] [Related]
5. A 5'-region polymorphism modulates promoter activity of the tumor suppressor gene MFSD2A.
Colombo F; Falvella FS; Galvan A; Frullanti E; Kunitoh H; Ushijima T; Dragani TA
Mol Cancer; 2011 Jul; 10():81. PubMed ID: 21736709
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the RASSF1A tumor suppressor gene in controlling cell migration.
Dallol A; Agathanggelou A; Tommasi S; Pfeifer GP; Maher ER; Latif F
Cancer Res; 2005 Sep; 65(17):7653-9. PubMed ID: 16140931
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
[TBL] [Abstract][Full Text] [Related]
8. Suppression of non-small cell lung cancer proliferation and tumorigenicity by DENND2D.
Ling B; Zheng H; Fu G; Yuan J; Shi T; Chen S; Liu Y; Liu Y; Cao Y; Zheng S; Guo S; Han N; Gao Y; Cheng S; Zhang K
Lung Cancer; 2013 Feb; 79(2):104-10. PubMed ID: 23182661
[TBL] [Abstract][Full Text] [Related]
9. Synaptic acetylcholinesterase targeted by microRNA-212 functions as a tumor suppressor in non-small cell lung cancer.
Lu L; Zhang X; Zhang B; Wu J; Zhang X
Int J Biochem Cell Biol; 2013 Nov; 45(11):2530-40. PubMed ID: 23974008
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of BTG3 in non-small cell lung cancer.
Chen X; Chen G; Cao X; Zhou Y; Yang T; Wei S
Biochem Biophys Res Commun; 2013 Jul; 437(1):173-8. PubMed ID: 23810394
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
[TBL] [Abstract][Full Text] [Related]
12. The cytoplasmic domain is critical to the tumor suppressor activity of TSLC1 in non-small cell lung cancer.
Mao X; Seidlitz E; Ghosh K; Murakami Y; Ghosh HP
Cancer Res; 2003 Nov; 63(22):7979-85. PubMed ID: 14633730
[TBL] [Abstract][Full Text] [Related]
13. COMMD9 promotes TFDP1/E2F1 transcriptional activity via interaction with TFDP1 in non-small cell lung cancer.
Zhan W; Wang W; Han T; Xie C; Zhang T; Gan M; Wang JB
Cell Signal; 2017 Jan; 30():59-66. PubMed ID: 27871936
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of suppressive role of RASSF1A gene at 3p21.3 in lung cancer cell line A549].
Zhang S; Shao K; Zhang CY; Zhou F; Wang W; Xiong MH; He J
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):908-11. PubMed ID: 16029530
[TBL] [Abstract][Full Text] [Related]
15. Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells.
Wesley UV; Tiwari S; Houghton AN
Int J Cancer; 2004 May; 109(6):855-66. PubMed ID: 15027119
[TBL] [Abstract][Full Text] [Related]
16. Fibulin 2 Is Hypermethylated and Suppresses Tumor Cell Proliferation through Inhibition of Cell Adhesion and Extracellular Matrix Genes in Non-Small Cell Lung Cancer.
Ma Y; Nenkov M; Schröder DC; Abubrig M; Gassler N; Chen Y
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769264
[TBL] [Abstract][Full Text] [Related]
17. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
18. Expression of alpha CP-4 inhibits cell cycle progression and suppresses tumorigenicity of lung cancer cells.
Castaño Z; Vergara-Irigaray N; Pajares MJ; Montuenga LM; Pio R
Int J Cancer; 2008 Apr; 122(7):1512-20. PubMed ID: 17973258
[TBL] [Abstract][Full Text] [Related]
19. FRMD3, a novel putative tumour suppressor in NSCLC.
Haase D; Meister M; Muley T; Hess J; Teurich S; Schnabel P; Hartenstein B; Angel P
Oncogene; 2007 Jun; 26(30):4464-8. PubMed ID: 17260017
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of the Kank1 gene inhibits human lung cancer progression in vitro and in vivo.
Gu Y; Zhang M
Oncol Rep; 2018 Sep; 40(3):1243-1250. PubMed ID: 29956815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
